Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
137,278,139
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
53,528,634
-
Shares change
-
+15,680,042
-
Total reported value, excl. options
-
$2,192,860,452
-
Value change
-
+$657,421,714
-
Put/Call ratio
-
113%
-
Number of buys
-
96
-
Number of sells
-
15
-
Price
-
$40.97
Institutional Holders of Vir Biotechnology, Inc. - Common Stock (VIR) as of Q2 2020
As of 30 Jun 2020 Vir Biotechnology, Inc. - Common Stock (VIR) had 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 53,528,634 shares of stock of the company.
Largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, Temasek Holdings (Private) Ltd, Alaska Permanent Fund Corp, BlackRock Inc., BAILLIE GIFFORD & CO, ICONIQ Capital, LLC, ALLIANCEBERNSTEIN L.P., Capital International Investors, JANUS HENDERSON GROUP PLC, and STATE STREET CORP.
This table shows 132 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.